The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants continues ...

Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...

Richard Adeleke, a doctoral researcher at Cornell University, New York, USA, and his research group have developed a groundbreaking vaccine that could protect people from both COVID-19 and the flu in ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

For quantitative detection of IgG against SARS-CoV-2 spike glycoprotein 1 (S1) enzyme-linked immunosorbent assay (ELISA; EUROIMMUN) was performed on an automated ANALYZER system (QuantiVac, EUROIMMUN) ...

SCORES of taxpayers have come forward claiming to be victims of an alleged scam where their refunds from the taxman ended up in bogus accounts opened using their details. In the past four weeks ...

Foods with a high glycemic index cause blood sugar to spike and then crash. Foods with a low glycemic index give you sustained energy because they are digested and absorbed slowly. Sweet potato is ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from COVID-19 and influenza and broader immunity to different flu strains.

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza ...